AlphaSense Raises $350M at $7.5B: What the J.P. Morgan and Goldman Co-Investment Signal Means for Accredited Investors

    AlphaSense Raises $350M at $7.5B: What the J.P. Morgan and Goldman Co-Investment Signal Means for Accredited Investors TL/DR: On June 3, 2026, AlphaSense announced a $350M raise at a $7.5B post-money valuation , up from...

    ByJeff Barnes, MBA
    ·12 min read
    Reviewed by Jeff Barnes — CEO of Angel Investors Network · MBA · $1B+ in Capital Formation
    AlphaSense Raises $350M at $7.5B: What the J.P. Morgan and Goldman Co-Investment Signal Means for Accredited Investors
    AlphaSense Raises $350M at $7.5B: What the J.P. Morgan and Goldman Co-Investment Signal Means for Accredited Investors

    TL/DR: On June 3, 2026, AlphaSense announced a $350M raise at a $7.5B post-money valuation, up from a $4B valuation in June 2024. The company now sits above $600M in annual recurring revenue (ARR), tripled from $200M in April 2024. Lead investors include Vitruvian Partners, Accenture Ventures, and J.P. Morgan Asset Management. Both J.P. Morgan Asset Management and Goldman Sachs Alternatives are returning investors who also pay enterprise subscription fees to use the platform. That dual relationship is the tell.

    The Round: $350M at $7.5B on $600M+ ARR

    This raise did not come as a surprise to anyone watching the company's ARR trajectory. AlphaSense crossed $200M ARR in April 2024, $400M in March 2025, $500M in October 2025, and $600M in Q1 2026. That is a tripling in under two years. At $7.5B, the company trades at roughly 12.5x ARR. That is a demanding multiple by any measure. The market is pricing in durable compounding, not a one-cycle story.

    The investor table tells you as much as the valuation does.

    Investor Role in This Round Type Notable Context
    Vitruvian Partners Lead (new) Growth equity Sophie Bower-Straziota joins board of directors
    Accenture Ventures Lead (new) Corporate / strategic First strategic channel partner. Embeds AlphaSense into Accenture client deployments.
    J.P. Morgan Asset Management Lead (new) Institutional asset manager J.P. Morgan Chase & Co. is also a named enterprise customer
    D.E. Shaw Ventures Participant (new) Quant hedge fund venture arm Long-term thesis on data infrastructure
    Goldman Sachs Alternatives Existing investor Institutional / alternatives Goldman manages $500B+ in alternatives assets and is also an enterprise customer
    CapitalG (Alphabet) Existing investor Corporate venture Continued from prior rounds
    Viking Global Investors Existing investor Crossover hedge fund Continued from prior rounds

    Proceeds are earmarked for AI platform investment, EMEA and APAC expansion (headcount there has already more than doubled), and a new global headquarters at Hudson Yards in New York City.

    What AlphaSense Actually Does

    AlphaSense was founded in 2011 by Jack Kokko and Raj Neervannan. Kokko, a Wharton MBA and former Morgan Stanley analyst, built the company after experiencing firsthand how much time analysts waste stitching together research from disconnected sources. The product solves that problem at scale.

    The platform indexes more than 500 million business documents: SEC filings, equity research from over 1,700 broker sources including Goldman Sachs and Morgan Stanley, earnings transcripts, industry reports, and news. In 2024, AlphaSense acquired Tegus for $930 million, adding 260,000+ expert interview transcripts covering 27,000+ companies. That transcript library is exclusive. No competitor has it.

    The June 2026 product launch of SuperAnalyst extends that content into agentic AI workflows. Instead of a user searching for information, SuperAnalyst executes multi-step research workflows on behalf of client teams. The platform already handles 33% quarter-over-quarter growth in generative AI query volume. Enterprise Intelligence deals, which let clients unify their proprietary internal documents with AlphaSense's external content, grew 185% year over year.

    Average revenue per customer has grown from $28,000 to $66,000 in under three years. The company now serves 7,000+ enterprise clients. That includes 90% of the S&P 100, 80% of top asset managers, 75% of top hedge funds, and 80% of top consultancies. Adobe, Amazon, American Express, Microsoft, Nvidia, and Pfizer are among the named customers.

    Why J.P. Morgan and Goldman Being Both Customers and Investors Is the Signal You Need to See

    When an institution pays recurring subscription fees for a software product and then separately commits equity capital to that company, it is not doing two unrelated things. It is telling you something about switching costs.

    J.P. Morgan Asset Management's Felise Agranoff said directly: “The company's transformative AI technology positions it well to grow market share and generate long-term value creation for investors.” Patrick McGoldrick, Managing Partner at J.P. Morgan Private Capital, called it “an essential intelligence platform for global enterprises.” J.P. Morgan is not experimenting here. It committed capital in the June 2024 round through J.P. Morgan Growth Equity Partners and returned in June 2026 through J.P. Morgan Asset Management.

    Goldman Sachs Alternatives manages over $500 billion across private equity, credit, real estate, and infrastructure. It has backed AlphaSense across multiple rounds. Goldman analysts and portfolio teams are active users. The investment is consistent with Goldman's thesis that AI-native fintech infrastructure will become non-discretionary enterprise spend.

    D.E. Shaw Ventures adds a different layer of credibility. D.E. Shaw runs some of the most sophisticated quantitative investment strategies in the world. Investing in a qualitative intelligence platform signals that the firm sees AlphaSense filling a gap its own quant workflows cannot easily close.

    This is not tourist capital. It is infrastructure conviction from institutions that have every incentive to evaluate the product critically before writing a check.

    The Competitive Moat: Why Bloomberg and FactSet Have Not Killed It

    The honest question for any accredited investor evaluating AlphaSense is: what stops Bloomberg or FactSet from replicating this? The answer is the content library. Bloomberg Terminal costs approximately $24,000 per seat annually and serves 325,000+ professionals. FactSet runs roughly $12,000 per seat and covers nearly 8,000 global clients. Both are strong on quantitative data and real-time pricing. Neither has 260,000 expert transcripts behind a proprietary wall.

    Platform Annual Cost / Seat Core Strength AI Development (2025–2026) Gap vs. AlphaSense
    AlphaSense $10,000–$20,000 Qualitative AI research. 500M+ docs. Exclusive expert transcripts. SuperAnalyst, Generative Search, Deep Research (June 2026) N/A (the benchmark)
    Bloomberg Terminal ~$24,000 Real-time pricing, trading data, Reuters news AI Document Search (late 2025). ASKB conversational interface (beta). Limited unstructured text NLP. Expensive for corporate and consulting use cases.
    FactSet ~$12,000 Financial data, ESG, Excel integration, API access AI Document Search to 85,000+ users. MCP server (Dec 2025). Primarily quantitative. Limited qualitative NLP and expert interview content.
    LSEG Workspace Custom enterprise Fixed income, FX data, Reuters feed Limited unstructured text search Textual search filters data fields rather than reading narrative research
    S&P Capital IQ Pro Custom enterprise Financial modeling, comparable company analysis ProntoNLP acquisition (2025). Drift AI for Excel (March 2026). Many users add AlphaSense for thematic research that Capital IQ cannot handle

    AlphaSense is Gartner's inaugural Magic Quadrant Leader for Competitive and Market Intelligence Platforms (2026), positioned highest on both the ability-to-execute and completeness-of-vision axes. That designation matters in enterprise procurement. It shifts buying decisions from individual champions to IT and procurement committees, which dramatically improves retention.

    The Tegus acquisition is the most defensible part of the moat. Building 260,000 expert transcripts from scratch would take a decade and require exclusive relationships with experts who are already committed. Bloomberg and FactSet know this. It is why both have pursued AI bolt-ons to existing products rather than competing directly on content depth.

    IPO Signals: Reading the Tea Leaves

    AlphaSense hired Samantha Greenberg as CFO in April 2026. The official press release described her mandate explicitly as including “capital markets strategy.” Greenberg's background spans Citadel, Goldman Sachs, Paulson & Co., and her own fund, Margate Capital Management. She has CFO and board experience at Nasdaq-listed companies. You do not hire that profile to run internal finance operations.

    CEO Jack Kokko told the Wall Street Journal that an IPO is “a possibility.” That phrasing is deliberate. The company has $600M+ ARR, a $7.5B valuation, institutional investors who need a public-market exit, a new CFO with a capital markets mandate, and 3,117 employees as of April 2026. All four ingredients for an IPO filing are in place. The question is timing, not direction.

    The valuation trajectory shows consistent re-rating: $1.7B in the 2022 Series D, $2.5B in the 2023 Series E, $4.0B in the 2024 Series F, and $7.5B today. A public-market debut at a 15x–18x ARR multiple, consistent with category-leading enterprise SaaS companies at IPO, would imply a range of $9B to $11B. That is not guaranteed. But it is the math that secondary market buyers are running.

    How Accredited Investors Can Access AlphaSense Equity Today

    AlphaSense is private. The company has filed no S-1 and announced no IPO date. What exists is a secondary market where employees and early investors occasionally sell existing shares to new buyers. That is the access point for accredited investors today.

    Four platforms handle these transactions. Each has meaningful trade-offs you need to understand before committing capital.

    Platform Structure Accreditation Required Notable Consideration
    Forge Global Direct secondary shares Yes Largest volume. Handles ROFR process. Settlement runs 45–60 days.
    EquityZen Fund interest (SPV) Yes You buy into an EquityZen fund holding AlphaSense shares, not direct shares
    Nasdaq Private Market Direct secondary shares Accredited / institutional Works primarily with employees and existing company investors as sellers
    Hiive Direct marketplace Yes Price data visible on platform. Recent indicative prices around $10.11/share.

    Before you act on any of these, understand three structural realities. First, AlphaSense holds a right of first refusal (ROFR) on secondary transfers. The company can match any offer and redirect the transaction. Your deal can fall through even after you commit. Second, secondary prices typically reflect the last primary round or a premium to it. You are entering at or above $7.5B. Third, there is no guaranteed liquidity event. An IPO may be three years out, structured as a direct listing, or replaced by a strategic acquisition. I have seen pre-IPO investments at similar stages take five years to resolve.

    The SEC defines an accredited investor under Rule 501 of Regulation D as an individual with income exceeding $200,000 (or $300,000 combined with a spouse) in each of the past two years, or a net worth exceeding $1 million excluding a primary residence, or a holder of a Series 7, 65, or 82 license. All four secondary platforms above require verification before allowing purchases.

    The Honest Risk Assessment

    The bull case is real: $600M+ ARR growing at venture pace, an exclusive content moat built over 15 years, institutional customers who invest alongside you, and a CFO hired to take the company public. The 12.5x ARR multiple is defensible if growth continues.

    The bear case is also real. At $7.5B, you are paying a premium that leaves limited margin for error. Private companies disclose less than public ones. Secondary transactions carry information asymmetry. The AI competitive landscape moves fast, and general-purpose LLMs are improving rapidly on document analysis tasks. AlphaSense's moat is content depth and workflow integration, not AI model superiority. A competitor with comparable content and equivalent AI could close the gap.

    I would not treat this as a bond. I would treat it as a concentrated position in a category leader with real IPO optionality, purchased at a price that demands continued execution.

    Actionable next step: If you want exposure, start with Forge Global's listing page, verify your accredited investor status, and request current bid/ask data. Compare the implied valuation on any available shares against the $7.5B primary round price. If secondary shares trade at a meaningful discount to $7.5B, that discount is your margin of safety. If they trade at a premium, the risk/reward tightens considerably. Check AlphaSense's SEC EDGAR Form D filing once it processes (typically within 15 days of close) at EDGAR's full-text search for the most current capital structure data.

    Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.

    Looking for investors?

    Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.

    Share
    J

    About the Author

    Jeff Barnes, MBA